137 related articles for article (PubMed ID: 16907946)
1. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
McParland PC; Kenyon S; Bell SC; Taylor DJ
BJOG; 2006 Aug; 113(8):976; author reply 976-7. PubMed ID: 16907946
[No Abstract] [Full Text] [Related]
2. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al.
Lamont RF; Dragovic B
BJOG; 2006 Jul; 113(7):850-1; author reply 851. PubMed ID: 16827775
[No Abstract] [Full Text] [Related]
3. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study.
Ugwumadu A; Yanamandra N; Hay P
BJOG; 2006 Jul; 113(7):851-2. PubMed ID: 16827776
[No Abstract] [Full Text] [Related]
4. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients.
Briery CM; Chauhan SP; Magann EF; Cushman JL; Morrison JC
J Miss State Med Assoc; 2011 Mar; 52(3):72-5. PubMed ID: 21476464
[TBL] [Abstract][Full Text] [Related]
6. Does oral metronidazole prevent preterm delivery in normal-risk pregnant women with asymptomatic bacterial vaginosis (BV)?
Lazar PA
J Fam Pract; 2000 Jun; 49(6):495-6. PubMed ID: 10923545
[No Abstract] [Full Text] [Related]
7. Metronidazole treatment of women with a positive fetal fibronectin test result.
Goldenberg RL; Klebanoff M; Carey JC; Macpherson C
Am J Obstet Gynecol; 2001 Aug; 185(2):485-6. PubMed ID: 11518914
[TBL] [Abstract][Full Text] [Related]
8. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.
Andrews WW; Sibai BM; Thom EA; Dudley D; Ernest JM; McNellis D; Leveno KJ; Wapner R; Moawad A; O'Sullivan MJ; Caritis SN; Iams JD; Langer O; Miodovnik M; Dombrowski M;
Obstet Gynecol; 2003 May; 101(5 Pt 1):847-55. PubMed ID: 12738139
[TBL] [Abstract][Full Text] [Related]
10. What we have learned from an antibiotic trial in fetal fibronectin positive women.
Andrews WW; Goldenberg RL;
Semin Perinatol; 2003 Jun; 27(3):231-8. PubMed ID: 12889590
[TBL] [Abstract][Full Text] [Related]
11. [Fetal fibronectin as predictor of preterm birth].
Roubille M; Mailliavin A; Biguet-Vernier B; Bon C; Golfier F; Pichot JC
Ann Biol Clin (Paris); 1999; 57(1):93-7. PubMed ID: 9920973
[No Abstract] [Full Text] [Related]
12. The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women.
Hendler I; Andrews WW; Carey CJ; Klebanoff MA; Noble WD; Sibai BM; Hillier SL; Dudley D; Ernest JM; Leveno KJ; Wapner R; Iams JD; Varner M; Moawad A; Miodovnik M; O'Sullivan MJ; Van Dorsten PJ;
Am J Obstet Gynecol; 2007 Nov; 197(5):488.e1-5. PubMed ID: 17980184
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes.
Yoneda S; Sakai M; Sasaki Y; Shiozaki A; Hidaka T; Saito S
J Obstet Gynaecol Res; 2007 Feb; 33(1):38-44. PubMed ID: 17212664
[TBL] [Abstract][Full Text] [Related]
14. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.
Grobman WA; Welshman EE; Calhoun EA
Am J Obstet Gynecol; 2004 Jul; 191(1):235-40. PubMed ID: 15295372
[TBL] [Abstract][Full Text] [Related]
15. Fetal fibronectin.
Koenn ME
Clin Lab Sci; 2002; 15(2):96-8, 115. PubMed ID: 12776771
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis.
Musaad SM; Melson LC; Boswell RD
Pathology; 2006 Oct; 38(5):473-4. PubMed ID: 17008297
[No Abstract] [Full Text] [Related]
17. Clinical utility of fetal fibronectin for predicting preterm birth.
Swamy GK; Simhan HN; Gammill HS; Heine RP
J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center.
Lowe MP; Zimmerman B; Hansen W
Am J Obstet Gynecol; 2004 Feb; 190(2):358-62. PubMed ID: 14981374
[TBL] [Abstract][Full Text] [Related]
19. A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing.
Stafford IP; Garite TJ; Dildy GA; Colon-Lucach A; Williams CA; Bobritchi B; Lapointe J; Bloch DA
Am J Obstet Gynecol; 2008 Aug; 199(2):131.e1-4. PubMed ID: 18355785
[TBL] [Abstract][Full Text] [Related]
20. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
Duhig KE; Chandiramani M; Seed PT; Briley AL; Kenyon AP; Shennan AH
BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
